Page last updated: 2024-08-20

homoarginine and Dilatation, Pathologic

homoarginine has been researched along with Dilatation, Pathologic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdalla, M; Assaf, M; Begmatov, H; Bode-Böger, SM; Bornstein, SR; Ghani, Z; Jarzebska, N; Khakshour, D; Martens-Lobenhoffer, J; Millan, JL; Mills, MT; Patel, K; Patel, MN; Rodionov, RN; Savinova, OV; Tamboli, P; Weiss, N1

Other Studies

1 other study(ies) available for homoarginine and Dilatation, Pathologic

ArticleYear
Homoarginine Supplementation Prevents Left Ventricular Dilatation and Preserves Systolic Function in a Model of Coronary Artery Disease.
    Journal of the American Heart Association, 2019, 07-16, Volume: 8, Issue:14

    Topics: Alkaline Phosphatase; Animals; Coronary Artery Disease; Diet, Atherogenic; Dilatation, Pathologic; Disease Models, Animal; Echocardiography; Endothelium; Fibrosis; Heart; Homoarginine; Hypercholesterolemia; Male; Mice; Mice, Transgenic; Mutation; Myocardium; Receptors, LDL; Stroke Volume; Survival Rate; Systole; Vascular Calcification; Ventricular Function, Left

2019